DGAP-News
341
0 Kommentare
Global Bioenergies S.A.: One step closer to industrial pilot testing
341 
0 KommentareDGAP-News: Global Bioenergies S.A. / Key word(s): Miscellaneous
Global Bioenergies S.A.: One step closer to industrial pilot testing
24.10.2014 / 09:46
---------------------------------------------------------------------
GLOBAL BIOENERGIES: One step closer to industrial pilot testing
Evry, October 23rd, 2014 - Global Bioenergies (Alternext Paris: ALGBE)
announces having reached, and even significantly surpassed, the first
productivity objective of the isobutene process defined in the context of
the "Investissements d'Avenir" financing. The ADEME defined this
productivity objective to ensure that the first industrial pilot trials be
successful.
In 2013, the ADEME (the French Environment and Energy Management Agency)
had granted an "Investissements d'Avenir" financing to Global Bioenergies
(4 million euros), Arkema
(0.8 million euros) and two CNRS laboratories (0.4 million euros). This
financing supports the development of Global Bioenergies' Isobutene process
and the use of this isobutene to produce methacrylic acid, a compound
notably used in the manufacturing of acrylic paints. It is a three year
project running from October 1st 2013 until October 1st 2016.
For Global Bioenergies, the project's objectives included the construction
of an industrial pilot in Pomacle-Bazancourt in collaboration with the
company Agro-industrie Recherches et Développements (ARD), a subsidiary of
the sugar major Cristal Union. The process also had to reach by the end of
the first year a level of productivity sufficient to carry out trials in
the said pilot.
After having successfully built and installed the industrial pilot on
schedule, Global Bioenergies confirms today having reached and even
significantly surpassed the productivity objective set for October 2014.
Concrete proof of the absence of product toxicity-which does not
accumulated in the fermenter thanks to its gaseous nature-has also been
observed in extended-fermentation tests. This key advantage opens the door
to the setting up of a continuous fermentation process associated with
reduced operational costs.
Denis Thibaut, Head of fermentation declares: "This result has been
obtained thanks to two factors: the creation of further improved strains,
and the optimization of fermentation protocols enabled by the deployment of
a unique fermentation platform in our Laboratories of Evry. The platform
counted seven fermenters in 2013 and is now strong of thirty five units."
Charles Nakamura, VP metabolic engineering adds: "Global Bioenergies has
made huge strides through the development milestones of its isobutene
process. The soon expected large scale trials will establish the industrial
value of this breakthrough innovation".
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one
in Europe, that is developing a process to convert renewable resources into
hydrocarbons through fermentation. The Company initially focused its
efforts on the production of isobutene, one of the most important
petrochemical building blocks that can be converted into fuels, plastics,
organic glass and elastomers. Global Bioenergies continues to improve the
yield of its process and is actively entering the industrial pilot testing
phase. The company recently replicated this success to propylene and
butadiene and is also looking to continue with other members of the gaseous
olefins family, key molecules at the heart of petrochemical industry.
Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 -
ALGBE)
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
---------------------------------------------------------------------
24.10.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
293111 24.10.2014
Evry, October 23rd, 2014 - Global Bioenergies (Alternext Paris: ALGBE)
announces having reached, and even significantly surpassed, the first
productivity objective of the isobutene process defined in the context of
the "Investissements d'Avenir" financing. The ADEME defined this
productivity objective to ensure that the first industrial pilot trials be
successful.
In 2013, the ADEME (the French Environment and Energy Management Agency)
had granted an "Investissements d'Avenir" financing to Global Bioenergies
(4 million euros), Arkema
(0.8 million euros) and two CNRS laboratories (0.4 million euros). This
financing supports the development of Global Bioenergies' Isobutene process
and the use of this isobutene to produce methacrylic acid, a compound
notably used in the manufacturing of acrylic paints. It is a three year
project running from October 1st 2013 until October 1st 2016.
For Global Bioenergies, the project's objectives included the construction
of an industrial pilot in Pomacle-Bazancourt in collaboration with the
company Agro-industrie Recherches et Développements (ARD), a subsidiary of
the sugar major Cristal Union. The process also had to reach by the end of
the first year a level of productivity sufficient to carry out trials in
the said pilot.
After having successfully built and installed the industrial pilot on
schedule, Global Bioenergies confirms today having reached and even
significantly surpassed the productivity objective set for October 2014.
Concrete proof of the absence of product toxicity-which does not
accumulated in the fermenter thanks to its gaseous nature-has also been
observed in extended-fermentation tests. This key advantage opens the door
to the setting up of a continuous fermentation process associated with
reduced operational costs.
Denis Thibaut, Head of fermentation declares: "This result has been
obtained thanks to two factors: the creation of further improved strains,
and the optimization of fermentation protocols enabled by the deployment of
a unique fermentation platform in our Laboratories of Evry. The platform
counted seven fermenters in 2013 and is now strong of thirty five units."
Charles Nakamura, VP metabolic engineering adds: "Global Bioenergies has
made huge strides through the development milestones of its isobutene
process. The soon expected large scale trials will establish the industrial
value of this breakthrough innovation".
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one
in Europe, that is developing a process to convert renewable resources into
hydrocarbons through fermentation. The Company initially focused its
efforts on the production of isobutene, one of the most important
petrochemical building blocks that can be converted into fuels, plastics,
organic glass and elastomers. Global Bioenergies continues to improve the
yield of its process and is actively entering the industrial pilot testing
phase. The company recently replicated this success to propylene and
butadiene and is also looking to continue with other members of the gaseous
olefins family, key molecules at the heart of petrochemical industry.
Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 -
ALGBE)
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Jean-Baptiste BARBAROUX
Head of Corporate Development
Tel : + 33 (0) 1 64 98 20 50
Email : jean-baptiste.barbaroux@global-bioenergies.com
---------------------------------------------------------------------
24.10.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
293111 24.10.2014
Aktuelle Themen
Weitere Artikel des Autors
Verfasst von EQS Group AG
URL kopieren
Per E-Mail teilen
Artikel drucken1 im Artikel enthaltener WertIm Artikel enthaltene Werte
Artikel zu den Werten
Auch bei Lesern beliebt
